July 20 (Reuters) - PeptiDream Inc 4587.T :
* Says it entered into a technology license agreement with
U.S.-based company Genentech Inc to nonexclusively license
PeptiDream's proprietary Peptide Discovery Platform System
(PDPS) technology
* Says PeptiDream will receive an undisclosed upfront
payment, annual technology access payments, and is eligible
to receive payments based on achievement of certain redetermined
development milestones
* Says PeptiDream is eligible to receive royalties on sales
of certain products that arise from use of the PDPS technology
Source text in Japanese:https://goo.gl/wmSBvb
Further company coverage: 4587.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: jun.cao.reuters.com@reuters.net))